ハイドロコロイドの世界市場：2024年～2031年

レポート概要

ハイドロコロイドの世界市場は、2023年に113億2,000万米ドルに達し、2024年から2031年の予測期間中にCAGR 5.8%で成長し、2031年には177億8,000万米ドルに達すると予測されています。

ハイドロコロイドは、親水性ポリマーが水中に分散したコロイドシステムです。これらのポリマーは、植物性、動物性、微生物性、合成由来など様々な供給源に由来し、一般的に多数のヒドロキシル基を含み、水との結合能力を高めています。様々な量の水が存在することで、ハイドロコロイドは環境の濃度や条件によって、ゲルや溶液のような異なる状態で存在することができます。

ハイドロコロイド製ドレッシングは、湿潤治癒環境を作り出し、滲出液を吸収し、創傷を外部汚染物質から保護する能力があるため、様々なタイプの創傷に臨床現場で広く使用されています。これらのドレッシングには、創傷液と接触するとゲルを形成する親水性ポリマーが含まれており、いくつかの利点があります。

ハイドロコロイドドレッシングによって形成されたゲル層は、創傷周囲の湿潤環境を維持するのに役立ち、これは最適な治癒に不可欠です。水分は細胞の移動、増殖、新組織の形成を促進し、治癒プロセスを加速します。

市場力学：

促進要因

創傷と外科手術の発生率の上昇

世界のハイドロコロイド市場の需要は、複数の要因によって牽引されています。主な要因の一つは、創傷と外科処置の発生率の上昇です。特に高齢化社会における急性・慢性創傷の増加は、ハイドロコロイド市場の重要な促進要因です。

外科手術による創傷は、小さな切開創から、より大きく複雑な創傷を残す大規模な処置まで、その複雑さはさまざまです。ハイドロコロイド製ドレッシング材は、治癒に不可欠な湿潤環境を維持する能力があるため、こうした創傷の管理に特に効果的です。創傷ケアを必要とする患者の数は、外科手術の数だけ存在します。各手術には感染症や治癒遅延を含む合併症のリスクが伴うため、効果的な創傷管理が不可欠です。

さらに、業界の主要企業は、この市場成長を促進するような技術の進歩や製品の発売を行っています。ハイドロコロイドドレッシングの技術革新には抗菌剤の統合が含まれます。これらの抗菌剤は、創傷治療における一般的な合併症である感染症の予防に役立ちます。創傷部位の微生物負荷を低減することで、抗菌ハイドロコロイドドレッシングは治癒率を高め、創傷関連の感染症の発生率を低下させることができます。

また、2023年8月、Scapa Healthcareは、ハイドロコロイドをベースとした医療機器を記録的な速さで発売する世界の消費者企業の支援に成功しました。同社は、医療グレードで皮膚に優しいハイドロコロイドの新製品投入を目指していましたが、規制に関する専門知識や社内で開発する能力が不足していました。

抑制要因

パッチに関連するアレルギー反応や皮膚刺激、従来のドレッシングと比較した高コスト、臨床知識やトレーニングの不足などの要因が市場の妨げになると予想されます。

市場セグメンテーション

世界のハイドロコロイド市場は、タイプ、用途、エンドユーザー、地域によって区分されます。

火傷分野はハイドロコロイドの世界市場シェアの約54.2%を占めます。

予測期間中、火傷分野が最大の市場シェアを占めると予想されます。ハイドロコロイドドレッシングは、湿潤治癒環境を作り出し維持する能力があるため、熱傷の管理に特に効果的です。

ハイドロコロイドドレッシングが提供する水分は、創傷治癒に不可欠な細胞移動に最適な微小環境を作り出す上で重要な役割を果たしています。湿潤環境では、線維芽細胞やケラチノサイトなどの細胞は創床を移動しやすくなり、肉芽組織の形成や再上皮化が促進され、最終的に治癒プロセス全体が促進されます。

さらに、この市場の成長を促進するような製品の発売を行う業界主要企業もあります。例えば、主要企業の一つであるカーディナルヘルス社のハイドロコロイドドレッシングは、効果的な創傷管理に不可欠な湿潤治癒環境を維持するために特別に設計された高度な創傷ケア製品です。このドレッシングは、褥瘡、軽度の火傷、術後の創傷など、様々なタイプの創傷に特に適しています。

同様に、3Mは3M Tegadermハイドロコロイドドレッシング、Nexcareハイドロコロイド、3M Nu-Derm標準ハイドロコロイドドレッシングを発売し、この市場の成長を後押ししています。

また、BAND-AIDブランドのHYDRO SEAL Purposeハイドロコロイドゲル包帯は、軽度の創傷を治療するための包括的なソリューションを提供し、1枚の包帯で6つの主要な利点を提供します。

市場地域別シェア

北米がハイドロコロイドの世界市場シェアの約43.1%を占める

予測期間中、北米地域が最大の市場シェアを占めると予想されます。糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍などの慢性創傷の有病率の上昇が、特に創傷ケアにおけるハイドロコロイド市場を大きく牽引しています。慢性創傷の治癒には特有の課題があり、水分レベルを効果的に管理し治癒を促進する特殊なドレッシング材が必要となります。ハイドロコロイドドレッシングはこうした目的に特に効果的であり、ヘルスケア分野での需要増につながっています。

さらに、北米では高齢化が進んでおり、慢性疾患や創傷にかかりやすくなっています。技術の進歩、医療費の増加、有利な償還政策がこの市場の成長を後押ししています。

例えば、医療製品の大手メーカーである3Mは、慢性創傷の管理に特化して設計された高度なハイドロコロイドドレッシングの新ラインの発売を発表しました。この革新的な製品ラインは北米のハイドロコロイド市場に大きな影響を与えると予想され、創傷ケア技術の進歩を推進する3Mのコミットメントを反映しています。

加えて、この地域には多くの主要プレーヤーが存在し、医療インフラが整備され、ハイドロコロイドの主要プレーヤーメーカーがこの市場の成長を牽引しています。例えば、2023年9月にラスベガスのRegenerexで、Pharma, Inc.は包括的な経営陣の結成を発表し、2023年第4四半期に製造事業を開始する予定です。同社は、傷を早く治し、合併症のリスクを減らすことを目的とした独自の処方を利用した創傷ケア製品を専門としています。

臨床評価では、同社製品で治療した慢性創傷の95％が90日以内に完全に閉鎖したことが実証されています。すべての製品には、Regenerex社独自のQBx成分が配合されており、創傷治癒に最適な環境作りをサポートします。ハイドロコロイドやコラーゲンベースの製品のような最新の創傷被覆材は、創傷の滲出液を吸収するように設計されているが、創傷部位を覆って保護するだけではないです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 創傷と外科処置の発生率の増加
  • 抑制要因
    • パッチに関連するアレルギー反応と皮膚の炎症
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 タイプ別

• 滅菌
• 非滅菌

第7章 用途別

• 火傷
• 慢性創傷
• 手術創
• 壊死創
• その他

第8章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• 3M
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Amparo medical Technologies.
• Scapa
• Sarasota Medical Products
• Cardinal Health.
• Convatec
• Fralock LLC
• Hi-Tech Products.
• AMERX Health Care
• DermaRite Industries, LLC.

第12章 付録

Report Overview

The Global Hydrocolloids Market reached US$ 11.32 billion in 2023 and is expected to reach US$ 17.78 billion by 2031 growing with a CAGR of 5.8% during the forecast period 2024-2031.

Hydrocolloids are colloidal systems where hydrophilic polymers are dispersed in water. These polymers can originate from various sources, including vegetable, animal, microbial, or synthetic origins, and they typically contain numerous hydroxyl groups, which enhance their ability to bind water. The presence of water in varying amounts allows hydrocolloids to exist in different states, such as gels or solutions, depending on the concentration and conditions of the environment.

Hydrocolloid dressings are widely used in clinical settings for various types of wounds due to their ability to create a moist healing environment, absorb exudate, and protect the wound from external contaminants. These dressings contain hydrophilic polymers that form a gel when they come into contact with wound fluid, providing several benefits.

The gel layer created by the hydrocolloid dressing helps maintain a moist environment around the wound, which is crucial for optimal healing. Moisture promotes cell migration, proliferation, and the formation of new tissue, accelerating the healing process.

Market Dynamics: Drivers

Rising incidence of wounds & surgical procedures

The demand for the global hydrocolloids market is driven by multiple factors. One of the primary factors is the rising incidence of wounds & surgical procedures. The increasing number of acute and chronic wounds, particularly among aging populations, is a significant driver of the hydrocolloid market.

Surgical wounds can vary in complexity, from minor incisions to extensive procedures that leave larger, more complex wounds. Hydrocolloid dressings are particularly effective for managing these wounds due to their ability to maintain a moist environment, which is crucial for healing. The number of surgical procedures is the vast population of patients requiring wound care. Each surgery entails a risk of complications, including infections and delayed healing, making effective wound management essential.

Moreover, key players in the industry have technological advancements and product launches that would drive this market growth. Innovations in hydrocolloid dressings include the integration of antimicrobial agents. These agents help prevent infections, a common complication in wound care. By reducing the microbial load at the wound site, antimicrobial hydrocolloid dressings can enhance healing rates and decrease the incidence of wound-related infections.

Also, in August 2023, Scapa Healthcare successfully assisted a global consumer company in launching a hydrocolloid-based medical device in record time. The company aimed to introduce a new medical-grade, skin-friendly hydrocolloid product but lacked the regulatory expertise and capabilities to develop it internally.

Restraints

Factors such as allergic reactions & skin irritations associated with the patches, high cost compared to traditional dressings, and lack of clinical knowledge and training are expected to hamper the market.

Market Segment Analysis

The global hydrocolloids market is segmented based on type, application, end-user, and region.

The burns segment accounted for approximately 54.2% of the global hydrocolloids market share

The burns segment is expected to hold the largest market share over the forecast period. Hydrocolloid dressings are particularly effective in managing burn wounds due to their ability to create and maintain a moist healing environment.

The moisture provided by hydrocolloid dressings plays a crucial role in creating an optimal microenvironment for cell migration, which is essential for wound healing. In a moist environment, cells such as fibroblasts and keratinocytes can more easily move across the wound bed, promoting the formation of granulation tissue and re-epithelialization, ultimately accelerating the overall healing process.

Moreover, key players in the industry product launch that would propel this market growth. For instance, one of the major players Cardinal Health Hydrocolloid Dressing is an advanced wound care product specifically designed to maintain a moist healing environment, which is crucial for effective wound management. This dressing is particularly suitable for various types of wounds, including pressure ulcers, minor burns, and post-operative wounds.

Similarly, 3M introduced the 3M Tegaderm hydrocolloid dressing, Nexcare hydrocolloid, and 3M Nu-Derm standard hydrocolloid dressings are helped to drive this market growth.

Also, other players in the industry introduced the BAND-AID Brand HYDRO SEAL Purpose Hydrocolloid Gel Bandages offer a comprehensive solution for treating minor wounds, providing six key benefits in a single bandage.

Market Geographical Share

North America accounted for approximately 43.1% of the global hydrocolloids market share

North America region is expected to hold the largest market share over the forecast period. The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, significantly drives the hydrocolloids market, particularly in wound care. Chronic wounds present unique challenges in healing and require specialized dressings that can effectively manage moisture levels and promote healing. Hydrocolloid dressings are particularly effective for these purposes, leading to increased demand in the healthcare sector.

Moreover, North America has a growing aging population, which is more susceptible to chronic conditions and wounds. Technological advancements, rising healthcare expenditure, and favorable reimbursement policies are helping to drive this market growth.

For instance, 3M, a leading manufacturer of medical products, announced the launch of a new line of advanced hydrocolloid dressings designed specifically for managing chronic wounds. This innovative product line is expected to have a significant impact on the hydrocolloids market in North America, reflecting 3M's commitment to driving progress in wound care technology.

In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, and key player manufacturers in the hydrocolloids driving this market growth. For instance, in Las Vegas Regenerex in September 2023, Pharma, Inc. announced the formation of its comprehensive management team and plans to start manufacturing operations in the fourth quarter of 2023. The company specializes in wound care products that utilize proprietary formulas aimed at healing wounds quickly, thereby reducing the risk of complications.

Clinical evaluations have demonstrated that 95% of chronic wounds treated with their products achieved complete closure within 90 days. All products incorporate Regenerex's unique QBx ingredients, which help create an optimal environment for wound healing. Modern wound dressings like hydrocolloids and collagen-based products are designed to absorb wound exudate, but they go beyond just covering and protecting the wound area.

Market Segmentation

By Type

Sterile

Non-Sterile

By Application

Burns

Chronic Wounds

Surgical Wounds

Necrotic Wounds

Others

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centres

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the hydrocolloids market include 3M, Amparo medical Technologies., Scapa, Sarasota Medical Products, Cardinal Health., Convatec, Fralock LLC, Hi Tech Products., AMERX Health Care, and DermaRite Industries, LLC. Among others.

Key Developments

In June 2024, The INKEY List launched its Hydrocolloid Invisible Pimple Patches, marking its entry into the pimple patch market. These patches are designed to help reduce the appearance of breakouts, particularly whiteheads, by utilizing hydrocolloid technology combined with active ingredients like salicylic acid. According to Dr. Joshua Zeichner, hydrocolloids are effective because they protect the outer skin layer, absorb excess fluid, and promote healing.

In April 2021, Scapa Healthcare announced enhancements at its Hydrocolloid Technology Center in Orangeburg, New York, as part of its commitment to meeting the increasing global demand for premium medical-grade hydrocolloid adhesive technologies. This facility specializes in the design, development, and manufacturing of hydrocolloid formulations used in various applications, including advanced wound care, ostomy care, and consumer wellness products.

Why Purchase the Report?

To visualize the global hydrocolloids market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the hydrocolloids market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global hydrocolloids market report would provide approximately 62 tables, 54 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Incidence of Wounds & Surgical Procedures
  • 4.1.2. Restraints
    • 4.1.2.1. Allergic Reactions & Skin Irritations Associated with the Patches
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Sterile *
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Non-Sterile

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Burns*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Chronic Wounds
• 7.4. Surgical Wounds
• 7.5. Necrotic Wounds
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Specialty Clinics
• 8.4. Ambulatory Surgical Centres
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. The U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. 3M *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Amparo medical Technologies.
• 11.3. Scapa
• 11.4. Sarasota Medical Products
• 11.5. Cardinal Health.
• 11.6. Convatec
• 11.7. Fralock LLC
• 11.8. Hi-Tech Products.
• 11.9. AMERX Health Care
• 11.10. DermaRite Industries, LLC. (*LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us